Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q2 EPS of ($0.11), $0.20 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $8.89 million versus the consensus estimate of $772 thousand.

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.